Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Recording of Earnings Call/ Conference Call Entero Healthcare Solutions Ltd - 544122 - Appointment Of Ernst & Young (EY) LLP As Internal Auditor Of The Company
Appointment of Ernst & Young (EY) LLP as Internal Auditor of the Company
Entero Healthcare Solutions Results Earnings Call for Q3FY24
Conference Call with Entero Healthcare Solutions Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript. Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of Newspaper Advertisement dated March 09, 2024. Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of Investor conference scheduled to be held on Wednesday, March 13, 2024 at 11:00 AM onwards Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation for the Quarter and Nine Months ended December 31, 2023 Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of balance 12,00,000 Equity Shares (representing 15% paid up equity share capital) of Getwell Medicare Solution Private Limited, the subsidiary company, from the erstwhile promoters. Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting Held On March 08, 2024
Outcome of Board Meeting held on March 08, 2024 Entero Healthcare Solutions Ltd - 544122 - Submission Of Financial Results For The Quarter And Nine Months Ended December 31, 2023
Submission of Financial Results for the Quarter and Nine Months ended December 31, 2023 Entero Healthcare Solutions Ltd - 544122 - Submission Of Financial Results For The Quarter And Nine Months Ended December 31, 2023
Submission of Financial Results for the Quarter and Nine Months ended December 31, 2023